HER2-postive breast cancer drugs show promise for bile duct cancer treatment

[News]

Drugs designed to target HER2-postive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial to be presented on Thursday at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.

More... (https://www.news-medical.net/news/20241023/HER2-postive-breast-cancer-drugs-show-promise-for-bile-duct-cancer-treatment.aspx)